Angion Biomedica Corp
Overview
Angion Biomedica Corp is a biotechnology company focused on developing small molecule therapeutics to address acute and chronic organ injuries, including acute kidney injury and other conditions. The company is committed to discovering and commercializing novel therapies that improve patient outcomes.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Angion Biomedica Corp in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.